7914 Shadeland Ave Indianapolis, IN 46250-2034
This 12,813-square-foot medical office building in Indianapolis, Indiana, is available for sale at $2,995,000. Built in 2005, the property boasts high-quality finishes and features 6,552 square feet of divisible second-floor space currently available for lease at $19.95 per square foot per year, NNN. The first floor is occupied by established tenants ATI Therapy and Labcorp. This prime location offers excellent visibility on Shadeland Avenue, across from Community Hospital North, and enjoys easy access to major roadways including I-465, SR 37, Shadeland Avenue, and E 82nd Street. Building signage is available. The property presents a compelling investment opportunity due to its strong tenant base, desirable location, and the potential for lease income generation from the available second-floor space. The building's size and layout allow for flexibility to accommodate a variety of medical practices or related businesses. This is a rare opportunity to acquire a well-maintained, strategically located medical office building in a thriving Indianapolis market.
-
Deborah L. Anderson, PT Physician
-
Ryan Consulting Group Information Services Business Management Consultant
-
LabCorp DNA Paternity Appointment Line TPA Paternity Testing Service
-
Labcorp Paternity Testing Service Diagnostic Center
-
ATI Physical Therapy Medical Clinic
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendProperty tax & assessments
Tax year 2023Comparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
ZO01 · Indianapolis, INIndianapolis. Always verify with local authorities before improvements.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.